These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3755336)

  • 1. The problem of local control in patients with advance breast cancer--a combined modality approach.
    Boyages J
    Australas Radiol; 1986 Feb; 30(1):60-2. PubMed ID: 3755336
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
    Rivkin SE; Glucksberg H; Foulkes M
    Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of metastatic breast cancer].
    Yahalom J; Biran S; Sulkes A
    Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
    Goodyear M
    J Clin Oncol; 1986 Mar; 4(3):442-4. PubMed ID: 3512787
    [No Abstract]   [Full Text] [Related]  

  • 5. Higher average received relative dose intensities of cyclophosphamide, methotrexate and 5-fluorouracil using a 24-hour method: implications for improved cure rates in breast cancer.
    Price LA; Hill BT
    Cancer Treat Rev; 1990 Sep; 17(2-3):191-6. PubMed ID: 2272033
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.
    Mohapatro SK; Dandapat MC; Padhi NC
    J Indian Med Assoc; 1992 Feb; 90(2):39-42. PubMed ID: 1588118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive combined modality therapy for advanced local-regional breast carcinoma.
    Loprinzi CL; Carbone PP; Tormey DC; Rosenbaum PR; Caldwell W; Kline JC; Steeves RA; Ramirez G
    J Clin Oncol; 1984 Mar; 2(3):157-63. PubMed ID: 6230422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer.
    Segaloff A; Hankey BF; Carter AC; Escher GC; Ansfield FJ; Talley RW
    Breast Cancer Res Treat; 1985; 5(3):311-9. PubMed ID: 3896353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raynaud's phenomenon after combined adjuvant chemotherapy for breast cancer.
    De Angelis R; Silveri F; Bugatti L; Filosa G
    Chemotherapy; 2003 Sep; 49(5):267-8. PubMed ID: 14504440
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK
    Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
    Tormey DC; Weinberg VE; Holland JF; Weiss RB; Glidewell OJ; Perloff M; Falkson G; Falkson HC; Henry PH; Leone LA
    J Clin Oncol; 1983 Feb; 1(2):138-45. PubMed ID: 6366133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
    Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
    J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sequential combination chemotherapy in metastatic cancer of the breast].
    Leone BA; Rabinovich MG; Strauss E; Arévalo E
    Medicina (B Aires); 1984; 44(1):15-22. PubMed ID: 6549523
    [No Abstract]   [Full Text] [Related]  

  • 15. Castration induced by cytotoxic chemotherapy.
    Brincker H; Mouridsen HT; Andersen KW; Rose C; Dombernowsky P
    J Clin Oncol; 1989 May; 7(5):679-80. PubMed ID: 2651582
    [No Abstract]   [Full Text] [Related]  

  • 16. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
    Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy versus observation in high-risk node-negative breast cancer patients.
    Mansour EG; Eudey L; Tormey DC; Shatila AH; Osborne CK; Gilchrist KW; Cooper MR; Falkson G
    J Natl Cancer Inst Monogr; 1992; (11):97-104. PubMed ID: 1627437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of adjuvant chemotherapy for breast cancer in a community practice.
    Rosenberg A; Winer EP; Cadman E
    Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy of breast cancer.
    Cooper RG
    Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose versus low-dose CMFP regimen in advanced breast cancer.
    Kumar A; Khanna NN; Pant GC; Khanna S
    J Surg Oncol; 1984 Apr; 25(4):300-2. PubMed ID: 6371385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.